The DOI matches its Crossref record; 136 of the 136 references it cites were found in a registry or an index.
Cytokine and Cytokine-Like Inflammation Markers, Endothelial Dysfunction, and Imbalanced Coagulation in Development of Diabetes and Its Complications
Abstract
CONTEXT: Recent developments indicate that pathophysiological mechanisms leading to beta-cell damage, insulin resistance, and the vascular complications of diabetes include an activation of the inflammation cascade, endothelial dysfunction, and procoagulant imbalance. Their circulating biomarkers may therefore provide opportunities for early diagnosis and targets for novel treatments. EVIDENCE: Circulating biomarkers of these pathways such as TNFalpha, IL-6, C-reactive protein (CRP) (inflammation), vascular cellular adhesion molecule-1, interstitial cellular adhesion molecule-1, E-selectin, von Willebrand factor (endothelial dysfunction), plasminogen activator inhibitor-1, fibrinogen, P-selectin (procoagulant state), and adiponectin (antiinflammation) may be associated with development of both type 1 and type 2 diabetes and some studies, particularly in type 2 diabetes, have demonstrated that certain biomarkers may have independent predictive value. Similarly studies have shown that these biomarkers may be associated with development of diabetic nephropathy and retinopathy, and again, particularly in type 2 diabetes, with cardiovascular events as well. Finally, the comorbidities of diabetes, namely obesity, insulin resistance, hyperglycemia, hypertension and dyslipidemia collectively aggravate these processes while antihyperglycemic interventions tend to ameliorate them. CONCLUSIONS: Increased CRP, IL-6, and TNFalpha, and especially interstitial cellular adhesion molecule-1, vascular cellular adhesion molecule-1, and E-selectin are associated with nephropathy, retinopathy, and cardiovascular disease in both type 1 and type 2 diabetes. Whereas further work is needed, it seems clear that these biomarkers are predictors of increasing morbidity in prediabetic and diabetic subjects and should be the focus of work testing their clinical utility to identify high-risk individuals as well as perhaps to target interventions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inflammation in atherosclerosis
Libby, P. (2002) · Nature · doi:10.1038/nature01323 · Cited by 8,315
Inflammation and insulin resistance
Shoelson, S. E. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29069 · Cited by 4,769
The adipocyte-secreted protein Acrp30 enhances hepatic insulin action
Berg, A. H., Combs, T. P., Du, X., Brownlee, M., & Scherer, P. E. (2001) · Nature Medicine · doi:10.1038/90992 · Cited by 2,526
Yudkin, J. S., Stehouwer, C. D. A., Emeis, J. J., & Coppack, S. W. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.4.972 · Cited by 2,465
Festa, A., D’Agostino, R., Howard, G., Mykkänen, L., Tracy, R. P., & Haffner, S. M. (2000) · Circulation · doi:10.1161/01.cir.102.1.42 · Cited by 2,358
Inflammation: the link between insulin resistance, obesity and diabetes
Dandona, P. (2004) · Trends in Immunology · doi:10.1016/j.it.2003.10.013 · Cited by 2,170
Esposito, K., Marfella, R., Ciotola, M., Di Palo, C., Giugliano, F., Giugliano, G., D'Armiento, M., D'Andrea, F., & Giugliano, D. (2004) · JAMA · doi:10.1001/jama.292.12.1440 · Cited by 2,126
The Finnish Diabetes Prevention Study (DPS)
Lindström, J., Louheranta, A., Mannelin, M., Rastas, M., Salminen, V., Eriksson, J., Uusitupa, M., Tuomilehto, J., & for the Finnish Diabetes Prevention Study Group (2003) · Diabetes Care · doi:10.2337/diacare.26.12.3230 · Cited by 1,848
Ouchi, N., Kihara, S., Arita, Y., Okamoto, Y., Maeda, K., Kuriyama, H., Hotta, K., Nishida, M., Takahashi, M., Muraguchi, M., et al. (2000) · Circulation · doi:10.1161/01.cir.102.11.1296 · Cited by 1,737
Ceriello, A., & Motz, E. (2004) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000122852.22604.78 · Cited by 1,378
Retinol-Binding Protein 4 and Insulin Resistance in Lean, Obese, and Diabetic Subjects
Graham, T. E., Yang, Q., Blüher, M., Hammarstedt, A., Ciaraldi, T. P., Henry, R. R., Wason, C. J., Oberbach, A., Jansson, P.-A., Smith, U., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa054862 · Cited by 1,319
Pickup, J. C., Mattock, M. B., Chusney, G. D., & Burt, D. (1997) · Diabetologia · doi:10.1007/s001250050822 · Cited by 1,242
Minireview: The Adipocyte—At the Crossroads of Energy Homeostasis, Inflammation, and Atherosclerosis
Rajala, M. W., & Scherer, P. E. (2003) · Endocrinology · doi:10.1210/en.2003-0580 · Cited by 1,190
Adiponectin and development of type 2 diabetes in the Pima Indian population
Lindsay, R. S., Funahashi, T., Hanson, R. L., Matsuzawa, Y., Tanaka, S., Tataranni, P. A., Knowler, W. C., & Krakoff, J. (2002) · The Lancet · doi:10.1016/s0140-6736(02)09335-2 · Cited by 1,094
Schmidt, M. I., Duncan, B. B., Sharrett, A. R., Lindberg, G., Savage, P. J., Offenbacher, S., Azambuja, M. I., Tracy, R. P., & Heiss, G. (1999) · The Lancet · doi:10.1016/s0140-6736(99)01046-6 · Cited by 1,071
Festa, A., D’Agostino, R., Tracy, R. P., & Haffner, S. M. (2002) · Diabetes · doi:10.2337/diabetes.51.4.1131 · Cited by 1,057
Suganami, T., Nishida, J., & Ogawa, Y. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000183883.72263.13 · Cited by 1,056 · cited 1×
“Adipose tissue from obese individuals contains activated macrophages that together with adipocytes produce inflammatory adipokines such as MCP-1, MIF, TNF , IL-6, procoagulant substances such as PAI-1, vasculoactive substances such as angiotensinogen and endothelin, and molecules that may contribute to insulin resista…”
BackgroundZiccardi, P., Nappo, F., Giugliano, G., Esposito, K., Marfella, R., Cioffi, M., D’Andrea, F., Molinari, A. M., & Giugliano, D. (2002) · Circulation · doi:10.1161/hc0702.104279 · Cited by 994 · cited 2×
“Importantly, weight reduction decreases levels of CRP, IL-6, and TNF , (72) and lowers sICAM-1, sVCAM-1, and P-selectin (73).”
BackgroundOxidative Stress and Cardiovascular Injury: Part I: Basic Mechanisms and In Vivo Monitoring of ROS
Griendling, K. K., & FitzGerald, G. A. (2003) · Circulation · doi:10.1161/01.cir.0000093660.86242.bb · Cited by 941
R�sen, P., Nawroth, P. P., King, G., M�ller, W., Tritschler, H.-J., & Packer, L. (2001) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.196 · Cited by 887
Stehouwer, C. D. A., Gall, M.-A., Twisk, J. W. R., Knudsen, E., Emeis, J. J., & Parving, H.-H. (2002) · Diabetes · doi:10.2337/diabetes.51.4.1157 · Cited by 652
Biomarkers of Endothelial Dysfunction and Risk of Type 2 Diabetes Mellitus
Meigs, J. B. (2004) · JAMA · doi:10.1001/jama.291.16.1978 · Cited by 643
Kern, T. S. (2007) · Journal of Diabetes Research · doi:10.1155/2007/95103 · Cited by 614
Inflammation and atherosclerosis: role of C-Reactive protein in risk assessment
Libby, P., & Ridker, P. M. (2004) · The American Journal of Medicine · doi:10.1016/j.amjmed.2004.02.006 · Cited by 595
Xiao, L., & Harrison, D. G. (2020) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2020.01.013 · Cited by 545
Stentz, F. B., Umpierrez, G. E., Cuervo, R., & Kitabchi, A. E. (2004) · Diabetes · doi:10.2337/diabetes.53.8.2079 · Cited by 497
The Pathologic Continuum of Diabetic Vascular Disease
Orasanu, G., & Plutzky, J. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.09.055 · Cited by 487
Detection of nitrotyrosine in the diabetic plasma: evidence of oxidative stress
Mercuri, F., Tonutti, L., Taboga, C., Ceriello, A., Assaloni, R., Motz, E., & Quagliaro, L. (2001) · Diabetologia · doi:10.1007/s001250100529 · Cited by 419
Tesch, G. H. (2008) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00016.2008 · Cited by 417
Oxidative Stress Is Associated with Adiposity and Insulin Resistance in Men
Urakawa, H., Katsuki, A., Sumida, Y., Gabazza, E. C., Murashima, S., Morioka, K., Maruyama, N., Kitagawa, N., Tanaka, T., Hori, Y., et al. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030202 · Cited by 416
Christiansen, T., Richelsen, B., & Bruun, J. M. (2005) · International Journal of Obesity · doi:10.1038/sj.ijo.0802839 · Cited by 411
Plasma fetuin-A levels and the risk of type 2 diabetes
Stefan, N., Fritsche, A., Weikert, C., Boeing, H., Joost, H.-G., Häring, H.-U., & Schulze, M. B. (2008) · Diabetes · doi:10.2337/db08-0538 · Cited by 379
Adiponectin and Future Coronary Heart Disease Events Among Men With Type 2 Diabetes
Schulze, M. B., Shai, I., Rimm, E. B., Li, T., Rifai, N., & Hu, F. B. (2005) · Diabetes · doi:10.2337/diabetes.54.2.534 · Cited by 365
Nagi, D. K., & Yudkin, J. S. (1993) · Diabetes Care · doi:10.2337/diacare.16.4.621 · Cited by 353
Salsalate Improves Glycemia and Inflammatory Parameters in Obese Young Adults
Fleischman, A., Shoelson, S. E., Bernier, R., & Goldfine, A. B. (2008) · Diabetes Care · doi:10.2337/dc07-1338 · Cited by 352
The Diabetes Prevention Program Research Group (2005) · Diabetes · doi:10.2337/diabetes.54.5.1566 · Cited by 333
Adiponectin and the Development of Type 2 Diabetes
Duncan, B. B., Schmidt, M. I., Pankow, J. S., Bang, H., Couper, D., Ballantyne, C. M., Hoogeveen, R. C., & Heiss, G. (2004) · Diabetes · doi:10.2337/diabetes.53.9.2473 · Cited by 324
The Finnish Diabetes Prevention Study
Uusitupa, M., Louheranta, A., Lindström, J., Valle, T., Sundvall, J., Eriksson, J., & Tuomilehto, J. (2000) · British Journal of Nutrition · doi:10.1017/s0007114500001070 · Cited by 306
Use of Salsalate to Target Inflammation in the Treatment of Insulin Resistance and Type 2 Diabetes
Goldfine, A. B., Silver, R., Aldhahi, W., Cai, D., Tatro, E., Lee, J., & Shoelson, S. E. (2008) · Clinical and Translational Science · doi:10.1111/j.1752-8062.2008.00026.x · Cited by 294
Tso, A. W. K., Xu, A., Sham, P. C., Wat, N. M. S., Wang, Y., Fong, C. H. Y., Cheung, B. M. Y., Janus, E. D., & Lam, K. S. L. (2007) · Diabetes Care · doi:10.2337/dc07-0413 · Cited by 291
Jager, A., van Hinsbergh, V. W. M., Kostense, P. J., Emeis, J. J., Yudkin, J. S., Nijpels, G., Dekker, J. M., Heine, R. J., Bouter, L. M., & Stehouwer, C. D. A. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.12.3071 · Cited by 288
Schram, M. T., Chaturvedi, N., Schalkwijk, C. G., Fuller, J. H., Stehouwer, C. D. A., & EURODIAB Prospective Complications Study Group (2005) · Diabetologia · doi:10.1007/s00125-004-1628-8 · Cited by 282
C-Reactive Protein and Glycemic Control in Adults With Diabetes
King, D. E., Mainous, A. G., Buchanan, T. A., & Pearson, W. S. (2003) · Diabetes Care · doi:10.2337/diacare.26.5.1535 · Cited by 280
Glucose metabolism and hyperglycemia
Giugliano, D., Ceriello, A., & Esposito, K. (2008) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/87.1.217s · Cited by 274
Plasma Adiponectin Is an Independent Predictor of Type 2 Diabetes in Asian Indians
Snehalatha, C., Mukesh, B., Simon, M., Viswanathan, V., Haffner, S. M., & Ramachandran, A. (2003) · Diabetes Care · doi:10.2337/diacare.26.12.3226 · Cited by 274
Improvement of Cardiovascular Risk Markers by Pioglitazone Is Independent From Glycemic Control
Pfützner, A., Marx, N., Lübben, G., Langenfeld, M., Walcher, D., Konrad, T., & Forst, T. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.03.041 · Cited by 268
Associations of Adiponectin, Resistin, and Tumor Necrosis Factor-α with Insulin Resistance
Hivert, M.-F., Sullivan, L. M., Fox, C. S., Nathan, D. M., D’Agostino, R. B., Wilson, P. W. F., & Meigs, J. B. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0425 · Cited by 262
Physical Activity and High-Sensitivity C-Reactive Protein
Plaisance, E. P., & Grandjean, P. W. (2006) · Sports Medicine · doi:10.2165/00007256-200636050-00006 · Cited by 242
Schulze, M. B., Rimm, E. B., Shai, I., Rifai, N., & Hu, F. B. (2004) · Diabetes Care · doi:10.2337/diacare.27.7.1680 · Cited by 237
Varma, V., Yao-Borengasser, A., Rasouli, N., Nolen, G. T., Phanavanh, B., Starks, T., Gurley, C., Simpson, P., McGehee, R. E., Kern, P. A., et al. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90885.2008 · Cited by 229
Adiponectin: Identification, physiology and clinical relevance in metabolic and vascular disease
Matsuzawa, Y. (2005) · Atherosclerosis Supplements · doi:10.1016/j.atherosclerosissup.2005.02.003 · Cited by 229
Cardozo, A. K., Kruhøffer, M., Leeman, R., Ørntoft, T., & Eizirik, D. L. (2001) · Diabetes · doi:10.2337/diabetes.50.5.909 · Cited by 229
Mantzoros, C. S., Li, T., Manson, J. E., Meigs, J. B., & Hu, F. B. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0372 · Cited by 224
Association of Oxidative Stress, Insulin Resistance, and Diabetes Risk Phenotypes
Meigs, J. B., Larson, M. G., Fox, C. S., Keaney, J. F., Vasan, R. S., & Benjamin, E. J. (2007) · Diabetes Care · doi:10.2337/dc07-0817 · Cited by 220
Inflammation and endothelial dysfunction are associated with retinopathy: the Hoorn Study
van Hecke, M. V., Dekker, J. M., Nijpels, G., Moll, A. C., Heine, R. J., Bouter, L. M., Polak, B. C. P., & Stehouwer, C. D. A. (2005) · Diabetologia · doi:10.1007/s00125-005-1799-y · Cited by 219
Plasma Leptin Levels Are Associated with Coronary Atherosclerosis in Type 2 Diabetes
Reilly, M. P., Iqbal, N., Schutta, M., Wolfe, M. L., Scally, M., Localio, A. R., Rader, D. J., & Kimmel, S. E. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031676 · Cited by 216
Jager, A., van Hinsbergh, V. W., Kostense, P. J., Emeis, J. J., Nijpels, G., Dekker, J. M., Heine, R. J., Bouter, L. M., & Stehouwer, C. D. (2000) · Diabetes · doi:10.2337/diabetes.49.3.485 · Cited by 214
Association of C-reactive protein with type 2 diabetes: prospective analysis and meta-analysis
Lee, C. C., Adler, A. I., Sandhu, M. S., Sharp, S. J., Forouhi, N. G., Erqou, S., Luben, R., Bingham, S., Khaw, K. T., & Wareham, N. J. (2009) · Diabetologia · doi:10.1007/s00125-009-1338-3 · Cited by 202
Natali, A., Toschi, E., Baldeweg, S., Ciociaro, D., Favilla, S., Saccà, L., & Ferrannini, E. (2006) · Diabetes · doi:10.2337/diabetes.55.04.06.db05-1076 · Cited by 199
Liu, S. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.15.1676 · Cited by 198
Costa, L. A., Canani, L. H., Lisbôa, H. R. K., Tres, G. S., & Gross, J. L. (2004) · Diabetic Medicine · doi:10.1111/j.1464-5491.2004.01124.x · Cited by 197
Soinio, M., Marniemi, J., Laakso, M., Lehto, S., & Rönnemaa, T. (2006) · Diabetes Care · doi:10.2337/diacare.29.02.06.dc05-1700 · Cited by 186
Hemostatic Markers of Endothelial Dysfunction and Risk of Incident Type 2 Diabetes
Meigs, J. B., O’Donnell, C. J., Tofler, G. H., Benjamin, E. J., Fox, C. S., Lipinska, I., Nathan, D. M., Sullivan, L. M., D’Agostino, R. B., & Wilson, P. W. F. (2006) · Diabetes · doi:10.2337/diabetes.55.02.06.db05-1041 · Cited by 184
Inflammation and diabetic nephropathy
Mora, C., & Navarro, J. F. (2006) · Current Diabetes Reports · doi:10.1007/s11892-006-0080-1 · Cited by 183
C-Reactive Protein and Incident Cardiovascular Events Among Men With Diabetes
Schulze, M. B., Rimm, E. B., Li, T., Rifai, N., Stampfer, M. J., & Hu, F. B. (2004) · Diabetes Care · doi:10.2337/diacare.27.4.889 · Cited by 180
Rakatzi, I., Mueller, H., Ritzeler, O., Tennagels, N., & Eckel, J. (2004) · Diabetologia · doi:10.1007/s00125-003-1293-3 · Cited by 180
Hung, J., McQuillan, B. M., Thompson, P. L., & Beilby, J. P. (2008) · International Journal of Obesity · doi:10.1038/sj.ijo.0803793 · Cited by 179
Dandona, P., Chaudhuri, A., Ghanim, H., & Mohanty, P. (2007) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2006.11.003 · Cited by 179
Herder, C., Baumert, J. J., Thorand, B., Köenig, W., de Jager, W., Meisinger, C., Illig, T., Martin, S., & Kolb, H. (2006) · Diabetologia · doi:10.1007/s00125-006-0190-y · Cited by 171
Association between dietary factors and plasma adiponectin concentrations in men
Pischon, T., Girman, C. J., Rifai, N., Hotamışlıgil, G. S., & Rimm, E. B. (2005) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/81.4.780 · Cited by 170
F., N., I., C., Mauro, M. D., Marco, R. D., M., M., K., B., A., M., & R., G. (2002) · Diabetologia · doi:10.1007/s00125-002-0879-5 · Cited by 168
Markers of inflammation and their clinical significance
Ballantyne, C. M., & Nambi, V. (2005) · Atherosclerosis Supplements · doi:10.1016/j.atherosclerosissup.2005.02.005 · Cited by 164
de Jager, J., Dekker, J. M., Kooy, A., Kostense, P. J., Nijpels, G., Heine, R. J., Bouter, L. M., & Stehouwer, C. D. A. (2006) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000215951.36219.a4 · Cited by 163
Adiponectin, Change in Adiponectin, and Progression to Diabetes in the Diabetes Prevention Program
Mather, K. J., Funahashi, T., Matsuzawa, Y., Edelstein, S., Bray, G. A., Kahn, S. E., Crandall, J., Marcovina, S., Goldstein, B., Goldberg, R., et al. (2008) · Diabetes · doi:10.2337/db07-1419 · Cited by 161
Self-citationFibrates and future PPARα agonists in the treatment of cardiovascular disease
Staels, B., Maes, M., & Zambon, A. (2008) · Nature Clinical Practice Cardiovascular Medicine · doi:10.1038/ncpcardio1278 · Cited by 160
Impact of Overweight on Chronic Microvascular Complications in Type 1 Diabetic Patients
Block, C. E. M. D., Leeuw, I. H. D., & Gaal, L. F. V. (2005) · Diabetes Care · doi:10.2337/diacare.28.7.1649 · Cited by 159
Interleukin-6: The Endocrine Cytokine
Papanicolaou, D. A. (2000) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.3.1331 · Cited by 158
Endothelial function and hypertension
Landmesser, U., & Drexler, H. (2007) · Current Opinion in Cardiology · doi:10.1097/hco.0b013e3281ca710d · Cited by 154
Caballero, A. E., Delgado, A., Aguilar-Salinas, C. A., Herrera, A. N., Castillo, J. L., Cabrera, T., Gomez-Perez, F. J., & Rull, J. A. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0019 · Cited by 151
Festa, A., Williams, K., Tracy, R. P., Wagenknecht, L. E., & Haffner, S. M. (2006) · Circulation · doi:10.1161/circulationaha.106.616177 · Cited by 147
Hayaishi-Okano, R., Yamasaki, Y., Katakami, N., Ohtoshi, K., Gorogawa, S.-I., Kuroda, A., Matsuhisa, M., Kosugi, K., Nishikawa, N., Kajimoto, Y., et al. (2002) · Diabetes Care · doi:10.2337/diacare.25.8.1432 · Cited by 142
Yoshida, N., Okumura, K.-I., & Aso, Y. (2005) · Metabolism · doi:10.1016/j.metabol.2004.09.014 · Cited by 138 · cited 1×
“stiffness that is increased in diabetes (137).”
Lajer, M., Tarnow, L., Jorsal, A., Teerlink, T., Parving, H., & Rossing, P. R. (2008) · Diabetes Care · doi:10.2337/dc07-1762 · Cited by 132
Targher, G., Bertolini, L., Zoppini, G., Zenari, L., & Falezza, G. (2005) · Diabetic Medicine · doi:10.1111/j.1464-5491.2005.01562.x · Cited by 128
Astrup, A. S., Tarnow, L., Pietraszek, L., Schalkwijk, C. G., Stehouwer, C. D. A., Parving, H., & Rossing, P. R. (2008) · Diabetes Care · doi:10.2337/dc07-1960 · Cited by 127
Albertini, J., Valensi, P. E., Lormeau, B., Aurousseau, M. H., Ferrière, F., Attali, J. R., & Gattegno, L. (1998) · Diabetes Care · doi:10.2337/diacare.21.6.1008 · Cited by 124
Macrophages, cytokines and β-cell death in Type 2 diabetes
Ehses, J. A., Böni‐Schnetzler, M., Faulenbach, M. V., & Donath, M. Y. (2008) · Biochemical Society Transactions · doi:10.1042/bst0360340 · Cited by 118
Duncan, B. B., Schmidt, M. I., Offenbacher, S., Wu, K. K., Savage, P. J., & HEISS, G. M. (1999) · Diabetes Care · doi:10.2337/diacare.22.5.767 · Cited by 111
Hadjadj, S., Aubert, R., Fumeron, F., Péan, F., Tichet, J., Roussel, R., Marre, M., & groups, S. A. D. S. (2005) · Diabetologia · doi:10.1007/s00125-005-1747-x · Cited by 110
Spijkerman, A. M. W., Gall, M. ‐., Tarnow, L., Twisk, J. W. R., Lauritzen, E., Lund‐Andersen, H., EMEIS, J. J., Parving, H. ‐., & Stehouwer, C. D. A. (2007) · Diabetic Medicine · doi:10.1111/j.1464-5491.2007.02217.x · Cited by 109
Subclinical Inflammation and Diabetic Polyneuropathy
Herder, C., Lankisch, M., Ziegler, D., Rathmann, W., Köenig, W., Illig, T., Döring, A., Thorand, B., Holle, R., Giani, G., et al. (2009) · Diabetes Care · doi:10.2337/dc08-2011 · Cited by 108
Lund, S. S., Tarnow, L., Stehouwer, C. D. A., Schalkwijk, C. G., Teerlink, T., Gram, J., Winther, K., Frandsen, M., Smidt, U., Pedersen, O. B., et al. (2008) · European Journal of Endocrinology · doi:10.1530/eje-07-0815 · Cited by 107
Roberts, C. K., Won, D., Pruthi, S., Lin, S. S., & Barnard, R. J. (2006) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2006.02.013 · Cited by 106
González‐Clemente, J. M., Mauricio, D., Richart, C., Broch, M., Caixàs, A., Megía, A., Giménez‐Palop, O., Simón, I., Martínez-Riquelme, A., Giménez‐Pérez, G., et al. (2005) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2005.02376.x · Cited by 103
Lopes-Virella, M. F., Carter, R. E., Gilbert, G. E., Klein, R. L., Jaffa, M. A., Jenkins, A. J., Lyons, T. J., Garvey, W. T., Virella, G., & and the DCCT/EDIC Cohort Study Group (2008) · Diabetes Care · doi:10.2337/dc08-0659 · Cited by 101
Kanaya, A. M., Fyr, C. W., Vittinghoff, E., Harris, T. B., Park, S. W., Goodpaster, B. H., Tylavsky, F., & Cummings, S. R. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.3.350 · Cited by 97
Stephens, J. W., Gable, D. R., Hurel, S. J., Miller, G. J., Cooper, J. A., & Humphries, S. E. (2005) · Clinical Chemistry · doi:10.1373/clinchem.2005.060194 · Cited by 97
Responses of inflammatory markers to a low-fat, high-carbohydrate diet: effects of energy intake
Kasim-Karakas, S. E., Tsodikov, A., Singh, U. S., & Jialal, I. (2006) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/83.4.774 · Cited by 95
Matsumoto, K., Sera, Y., Ueki, Y., Inukai, G., Niiro, E., & Miyake, S. (2002) · Diabetic Medicine · doi:10.1046/j.1464-5491.2002.00799.x · Cited by 95
Elevated C-Reactive Protein Levels in the Development of Type 1 Diabetes
Chase, H. P., Cooper, S., Osberg, I. M., Stene, L. C., Barriga, K. J., Norris, J. M., Eisenbarth, G. S., & Rewers, M. (2004) · Diabetes · doi:10.2337/diabetes.53.10.2569 · Cited by 94
Kang, E. S., Kim, H. J., Ahn, C. W., Park, C. W., Soo, B., Lim, S. K., Kim, K. R., & Lee, H. C. (2005) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2004.11.014 · Cited by 91
Persson, F., Rossing, P. R., Hovind, P. H., Stehouwer, C. D. A., Schalkwijk, C. G., Tarnow, L., & Parving, H. (2008) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365510802187226 · Cited by 88
Soedamah‐Muthu, S. S., Chaturvedi, N., Schalkwijk, C. G., Stehouwer, C. D. A., Ebeling, P., & Fuller, J. (2006) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2005.06.005 · Cited by 85
Araki, S., Haneda, M., Koya, D., Sugimoto, T., Isshiki, K., Chin‒Kanasaki, M., Uzu, T., & Kashiwagi, A. (2007) · Diabetologia · doi:10.1007/s00125-006-0586-8 · Cited by 83
Saremi, A., Anderson, R. J., Luo, P., MORITZ, T. E., Schwenke, D. C., Allison, M., & Reaven, P. D. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.07.031 · Cited by 80
Jensterle, M., Šebeštjen, M., Janež, A., Preželj, J., Kocjan, T., Keber, I., & Pfeifer, M. (2008) · European Journal of Endocrinology · doi:10.1530/eje-08-0507 · Cited by 80
The role of macrophage migration inhibitory factor on glucose metabolism and diabetes
Toso, C., Emamaullee, J. A., Merani, S., & Shapiro, A. M. J. (2008) · Diabetologia · doi:10.1007/s00125-008-1063-3 · Cited by 78
van Oostrom, A. J. H. H. M., van Wijk, J. P. H., & Cabezas, M. C. (2004) · Drugs · doi:10.2165/00003495-200464002-00004 · Cited by 77
Maahs, D. M., Ogden, L. G., Kretowski, A. J., Snell‐Bergeon, J. K., Kinney, G. L., Berl, T., & Rewers, M. (2007) · Diabetes · doi:10.2337/db07-0539 · Cited by 76
The Effect of Weight Loss on a Stable Biomarker of Inflammation, C-Reactive Protein
Dietrich, M., & Jialal, I. (2005) · Nutrition Reviews · doi:10.1111/j.1753-4887.2005.tb00107.x · Cited by 75
Kato, K., Osawa, H., Ochi, M., Kusunoki, Y., Ebisui, O., Ohno, K., Ohashi, J., Shimizu, I., Fujii, Y., Tanimoto, M., et al. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.03063.x · Cited by 74
Altered chemokine levels in individuals at risk of Type 1 diabetes mellitus
Hanifi-Moghaddam, P., Kappler, S., Seißler, J., Müller-Scholze, S., Martin, S., Roep, B. O., Straßburger, K., Kolb, H., & Schloot, N. C. (2005) · Diabetic Medicine · doi:10.1111/j.1464-5491.2005.01743.x · Cited by 73
Adiponectin may play a part in the pathogenesis of diabetic retinopathy
Yilmaz, M., Sönmez, A., Açıkel, C., Celık, T., Bingöl, N., Pinar, M., Bayraktar, Z., & Özata, M. (2004) · European Journal of Endocrinology · doi:10.1530/eje.0.1510135 · Cited by 72
Godsland, I., Crook, D., Proudler, A., & Stevenson, J. (2005) · Journal of Clinical Endocrinology and Metabolism · doi:10.1210/jc.2004-1292 · Cited by 70
Eliasson, M., Jansson, J., Lindahl, B., & Stegmayr, B. (2003) · Cardiovascular Diabetology · doi:10.1186/1475-2840-2-19 · Cited by 68
Adiponectin, Diabetes, and Coronary Heart Disease in Older Persons: Unraveling the Paradox
Sattar, N. A., & Nelson, S. M. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1435 · Cited by 63
Briley, L. P., & Szczech, L. A. M. (2006) · Seminars in Dialysis · doi:10.1111/j.1525-139x.2006.00119.x · Cited by 63
Diabetic Retinopathy: From Pathogenesis to Treatment
Chakrabarti, S. (2007) · Journal of Diabetes Research · doi:10.1155/2007/69527 · Cited by 62
Silha, J. V., Nyomba, B. L. G., Leslie, W. D., & Murphy, L. J. (2007) · Diabetes Care · doi:10.2337/dc06-1073 · Cited by 57
Lindmark, S., Burén, J., & Eriksson, J. W. (2006) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02593.x · Cited by 52
Serum Adiponectin and Renal Dysfunction in Men With Type 2 Diabetes
Lin, J., Hu, F. B., & Curhan, G. C. (2007) · Diabetes Care · doi:10.2337/dc06-1296 · Cited by 51
Sigurdardottir, V., Fagerberg, B., & Hulthe, J. (2004) · Diabetes Care · doi:10.2337/diacare.27.4.880 · Cited by 50
Hämäläinen, H., Rönnemaa, T., Virtanen, A., Lindström, J., Eriksson, J. G., Valle, T. T., Ilanne‐Parikka, P., Keinanen-Kiukaanniemi, S. M., Rastas, M., Aunola, S., et al. (2005) · Diabetologia · doi:10.1007/s00125-005-1938-5 · Cited by 50
(2005) · Diabetes Care · doi:10.2337/diacare.28.10.2472 · Cited by 45
Urinary F2‐Isoprostanes Are Not Associated with Increased Risk of Type 2 Diabetes
Il’yasova, D., Morrow, J. D., & Wagenknecht, L. E. (2005) · Obesity Research · doi:10.1038/oby.2005.201 · Cited by 40
Kamgar, M., Nobakhthaghighi, N., Shamshirsaz, A. A., Estacio, R. O., McFann, K., & Schrier, R. W. (2006) · Kidney International · doi:10.1038/sj.ki.5000355 · Cited by 35
Hoo, R. L. C., Chow, W. S., Yau, M.-H., Xu, A., Tso, A. W. K., Tse, H., Fong, C. H.-Y., Tam, S., Chan, L., & Lam, K. S. L. (2007) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.107.152462 · Cited by 34
Hwang, J. S., Shin, C. H., & Yang, S. W. (2005) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2004.00398.x · Cited by 33
Determinants of adiponectin levels in young people with Type 1 diabetes
Barnes, M., Curran‐Everett, D., Hamman, R. F., Maahs, D. M., Mayer‐Davis, E. J., D’Agostino, R. B., West, N., & Dabelea, D. (2008) · Diabetic Medicine · doi:10.1111/j.1464-5491.2007.02374.x · Cited by 31
Diabetes treatments have differential effects on nontraditional cardiovascular risk factors
Fonseca, V. A., Theuma, P., Mudaliar, S. R., Leissinger, C., Clejan, S., & Henry, R. R. (2005) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2005.05.009 · Cited by 30
Differences in LDL Oxidizability by Glycemic Status
Schwenke, D. C., D’Agostino, R. B., Goff, D. C., Karter, A. J., Rewers, M., & Wagenknecht, L. E. (2003) · Diabetes Care · doi:10.2337/diacare.26.5.1449 · Cited by 25
Plasma nitrotyrosine levels, antioxidant vitamins and hyperglycaemia
Bo, S., Gambino, R., Guidi, S., Silli, B., Gentile, L., Cassader, M., & Pagano, G. F. (2005) · Diabetic Medicine · doi:10.1111/j.1464-5491.2005.01588.x · Cited by 23
Thiazolidinediones: Beyond Glycemic Control
Reynolds, K., & Goldberg, R. B. (2006) · Treatments in Endocrinology · doi:10.2165/00024677-200605010-00004 · Cited by 21
Self-citationAssociation of soluble CD40 ligand with carotid atherosclerosis in Japanese type 1 diabetic patients
Katakami, N., Kaneto, H., Matsuhisa, M., Miyatsuka, T., Sakamoto, K., Kawamori, D., Yoshiuchi, K., Nakamura, Y., Kato, K., Yamamoto, K., et al. (2006) · Diabetologia · doi:10.1007/s00125-006-0281-9 · Cited by 21
Erşanlı, D., Top, C., Öncül, O., Aydin, A., & Terekeci, H. (2007) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365510601110148 · Cited by 7
Cited by
Pathophysiology of type 2 diabetes mellitus
Galicia-Garcia, U., Benito-Vicente, A., Jebari, S., Larrea-Sebal, A., Siddiqi, H., Uribe, K. B., Ostolaza, H., & Martín, C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21176275 · Cited by 3,360
“This balance is altered in T2DM leading to alteration of the physicochemical properties of the vascular wall via endothelial dysfunction, oxidative stress, platelet hyperreactivity, and inflammation [240,241].”
BackgroundOxidative stress, insulin signaling, and diabetes
Rains, J. L., & Jain, S. K. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.12.006 · Cited by 1,435
The Role of Oxidative Stress and Antioxidants in Diabetic Wound Healing
Deng, L., Du, C., Song, P., Chen, T., Rui, S., Armstrong, D. G., & Deng, W. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/8852759 · Cited by 763
Molecular Mechanisms Linking Oxidative Stress and Diabetes Mellitus
Yaribeygi, H., Sathyapalan, T., Atkin, S. L., & Sahebkar, A. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/8609213 · Cited by 685
Domingueti, C. P., Dusse, L. M. S., Carvalho, M. D. G., de Sousa, L. P., Gomes, K. B., & Fernandes, A. P. (2016) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2015.12.018 · Cited by 647
Metadata
- Authors
- Goldberg, R. B.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2009-09-01
- Volume
- 94
- Issue
- 9
- Pages
- 3171-3182
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2052882363
- Cited by
- 644
- References
- 136
- FWCI
- 33.52
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.